Filter by patients with: All

What is ME/CFS Phase III Ampligen Study?

Category: Others

false

The ME/CFE Phase III Ampligen Study is a clinical trial looking at the treatment of severely debilitating chronic fatigue syndrome with ampligen infusions.

See patients taking ME/CFS Phase III Ampligen Study

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Support immune health 1 1
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See 1 patient that have used ME/CFS Phase III Ampligen Study

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with ME/CFS Phase III Ampligen Study

Side effect Patients Percentage
Adherence
Adherence Evaluations Percentage
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 0
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 0
Last updated:
There are no evaluations for ME/CFS Phase III Ampligen Study.